Radar › Companies › Healthcare · Gelderland
Radar · Healthcare in Gelderland

Best Healthcare Companies in Gelderland, Netherlands

The 48 best Healthcare companies in Gelderland, Netherlands in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Lead Pharma.

48companies tracked
$30Mdisclosed funding
0unicorns
5have raised

Ranked: Best Healthcare companies in Gelderland

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1Lead Pharma
Small molecules therapeutics against cancer and autoimmune diseases
$27M115 mo agoEarly Stage—2007WordPressMySQLPHP+16228 patents
Small‑molecule modulators of ERRα and RORγ nuclear receptors for therapeutic use
—
2ConnectedCare
Developer of digital health solutions for care collaboration and sustainable lifestyles
$1M104 mo agoFunding Raised—2010———
3Innosieve Diagnostics
Provider of microbial diagnostic test kits
$769K64 mo agoFunding Raised—2007—5 patents
Microfilter centrifuge tubes for integrated sample filtration in laboratory centrifugation
—
4TROPIQ Health Sciences
Barcoded live insect screening technology
$464K54 mo agoFunding RaisedKoen Dechering
Cofounder and VP of business development
2012—16 patents
Patents concentrated in health & consumer products
—
5Hospitainer
Provider of healthcare facilities deployment services
$203K68 mo agoFunding RaisedRolof Mulder
Founder
2010WordPressMySQLPHP+8—1 expansion
6Propria
Chain of mental health clinics
$121K79 mo agoSeed—2008———
7Synthon
Dutch Biopharma company developing generics as well as biologicals, with expertise in Antibody-Drug-Conjugates
—41 mo agoAcquiredAnish Mehta
CEO
1991Apple iCloud MailMicrosoft 365PHP+191,050 patents
Patents concentrated in chemistry & materials
1 job opening
8Predica Diagnostics
Manufacturer of cancer detection kits
—48 mo agoSeedMarco Boer
Co-Founder & CEO
2020———

Top 12 Healthcare companies in Gelderland

#1
Funding Raised · Nijmegen, Gelderland · founded 2012 · 15 employees
$463.9Kraised
▾

TROPIQ Health Sciences offers high throughput screening services for the discovery & development of vector control agents and antimalarials. The company offers services such as live insect barcoded screening, In vitro high throughput assays for asexual blood stages, gametocytes, oocysts, & sporozoite. The company also offers monoclonal antibodies.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Funding rounds
  • Feb 2022Grant (prize money)$2.1K
  • Feb 2017Grant (prize money)$461.8K
Founders & team
Koen DecheringCofounder and VP of business developmentMichiel Van AlstCEO
Investors
Europa
#2
Funding Raised · Wageningen, Gelderland · founded 2007 · 3 employees
$768.8Kraised
▾

Provider of microbial diagnostic test kits. The company offers Sieve-ID diagnostic platform, which enables rapid and reliable analysis of microbial contamination. The platform uses a solid-phase cytometry process: microbes are retained on a membrane, washed, stained, and then analyzed using the automated MuScan optical scanning device.

Funding rounds
  • Apr 2021Grant (prize money)$66.1K
  • Jan 2021Grant (prize money)$702.7K
Investors
Europa
Tech stack
BootstrapAnimate.CssNginxJqueryOwl Carousel
#3
Early Stage · Nijmegen, Gelderland · founded 2007 · 42 employees
$27.4Mraised
▾

Lead Pharma is a company that discovers, develops and commercializes innovative therapeutics against cancer and autoimmune diseases. It currently has three key programs in development: novel inhibitors of RORyt (immunology target); small molecule drugs targeting estrogen-related receptor α (ERRα) (regulator of energy metabolism); LXR agonists critical for cholesterol metabolism and (reverse) transport, lipogenesis, glucose homeostasis, inflammation and innate immunity. Lead Pharma´s approach has been validated by a partnership with Sanofi covering the entire lead program RORyt. The company expects to close one or two additional development partnerships for its programs with pharma companies.

Investors
Rijksdienst voor Ondernemend Nederland, Oost NL, BioX Biosciences BV, Europa, BOM, Waterman Ventures
Tech stack
WordpressMysqlPhpUnixBootstrapYoast Seo
#4
Funding Raised · Vaassen, Gelderland · founded 2010
$202.8Kraised
▾

Provider of healthcare facilities deployment services

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Hiring: 1 hiring post in 12 mo (public) · hiring: Head of Sales
Activity: 1 expansions announced in 12 mo
Funding rounds
  • Dec 2020Grant (prize money)$202.8K
Founders & team
Rolof MulderFounder
Investors
Europa, Oost NL
Tech stack
Google AnalyticsGoogle Font ApiMysqlNginxOpen GraphOpenresty
#5
Funding Raised · Dieren, Gelderland · founded 2010 · 7 employees
$1.1Mraised
▾

Developer of digital health solutions for care collaboration and sustainable lifestyles. It designs and develops digital tools and services to improve healthcare experiences and promote sustainable living. These solutions focus on enhancing collaboration among caregivers, patients, and healthcare professionals, using persuasive design techniques and social robotics to encourage behavior change. The company employs user research and participatory design methods to ensure solutions meet the needs of diverse users. It also provides software development and business development support to bring innovations to market. Areas of expertise include care collaboration, sustainability, persuasive technology, and social robotics.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 308 LinkedIn followers
Funding rounds
  • Dec 2017Grant (prize money)$562K
  • Jan 2017Grant (prize money)$501.5K
Investors
Europa
Tech stack
WordpressMysqlPhpUnixAnimate.CssWpbakery
#6
Seed · Wijchen, Gelderland · founded 2008
$121Kraised
▾

Chain of mental health clinics

Tech stack
WordpressMysqlPhpBootstrapWp RocketResponsive Lightbox & Gallery
#7
Acquired · Nijmegen, Gelderland · founded 1991 · 1600 employees
—raised
▾

Synthon is a Dutch Biopharma company developing generics as well as biologicals, with expertise in Antibody-Drug-Conjugates. In generics, it manufactures drugs in categories such as antiallergics, antiinfectives, oncology, CNS, cardiovascular, urology. In Biopharmaceuticals, it has 2 main areas of focus, Oncology and Multiple Sclerosis/AutoImmune/Neurodegenerative diseases. In MS, it makes the biosimilar to Copaxone, and has received regulatory clearance. In oncology, it has the following drugs: Anastrozole (breast cancer), Bicalutamide (prostate cancer), Exemestane (breast cancer), Ibandronate (skeletal events related to bone metastases), Letrozole (breast cancer), Ondansetron (nausea after chemotherapy), Zoledronic acid (skeletal events related to bone metastases). It has partnered with Amgen to make Trastuzumab (Herceptin biosimilar). It has an expertise in ADCs. Its anti-HER2 ADC is currently in early clinical trials.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 48k LinkedIn followers — 24.4% of this cohort's audience · 99 engagements/post (2.9× cohort median)
Hiring: 3 hiring posts in 12 mo (public) · momentum +1 · hiring: Corporate Director – Business, right hand
Founders & team
Anish MehtaCEO
Investors
Gov.cz
Tech stack
Amazon SesAmazon Web ServicesApple Icloud MailBabelCloudflareCloudflare Bot Management
#8
Seed · Nijmegen, Gelderland · founded 2020 · 5 employees
—raised
▾

Manufacturer of cancer detection kits

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Activity: 1 partnerships (incl. Predica Diagnostics) announced in 12 mo
Founders & team
Marco BoerCo-Founder & CEO
Investors
Tech Transfer, Oost NL, 819 Capital Partners
#9
Funding Raised · Nijmegen, Gelderland · founded 1951 · 113 employees
—raised
▾

Standalone general clinic

LinkedIn Pulse recent public activity · Jul 2026
Audience: 94k LinkedIn followers — 47.7% of this cohort's audience · 95 engagements/post (2.8× cohort median)
Hiring: 1 hiring post in 12 mo (public) · hiring: Intensive Care, Manager bedrijfsvoering KNO
Investors
Europa, HHS, Starthubs
Tech stack
Apple Icloud MailAzureAzure MonitorCart FunctionalityCloudflareCloudflare Bot Management
#10
Series A · Nijmegen, Gelderland · founded 1997 · 131 employees
—raised
▾

Provider of drug discovery and development services

#11
Funding Raised · Nijmegen, Gelderland · founded 2005 · 15 employees
—raised
▾

Operator of a pharmaceutical development company intended for complex analytical and pharmaceutical development projects. The company focuses on CRO service activities such as drug repositioning, repurposing and reformulation and developing value-added generic drugs, life cycle management of branded drug products, enabling consumers to get medicines and treatments for different diseases.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Founders & team
Hans PlatteeuwFounder & CEO
Investors
European Union
Tech stack
Contact Form 7CookieyesCore-JsElementorFont AwesomeGoogle Analytics
#12
Funding Raised · Nijmegen, Gelderland · founded 2012 · 8 employees
—raised
▾

NBCL offers services for the development and commercialization of novel biomarker assays. Besides novel biomarker assay commercialization, the company can also provide with contract research services in immunoassay design, development, optimization, and validation. Other services offered include assay design and development, assay optimization and verification for robust and sustainable manufacturing of in vitro diagnostic products, assay validation, and product development under design control.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Hiring: 1 hiring post in 12 mo (public) · hiring: Scientist
Funding rounds
  • Jun 2016Grant (prize money)—
Investors
Europa, Oost NL, Vlasroot
Tech stack
Wix EcommerceWixReactGoogle CloudPolyfillLodash

Funding & investor landscape

$30Mtotal disclosed funding
6companies funded
7disclosed rounds
0rounds last 90 days
Most active investors
Europa7 rounds
Oost NL7 rounds
819 Capital Partners1 rounds
AIB CAPITAL & CO1 rounds
BOM1 rounds
BioX Biosciences BV1 rounds
Blue HK Investments1 rounds
Blue Ocean Xlerator1 rounds
Carduso Capital1 rounds
European Union1 rounds

Notable founders

Koen Dechering
Cofounder and VP of business development · TROPIQ Health Sciences
Michiel Van Alst
CEO · TROPIQ Health Sciences
Rolof Mulder
Founder · Hospitainer
Anish Mehta
CEO · Synthon
Marco Boer
Co-Founder & CEO · Predica Diagnostics
Hans Platteeuw
Founder & CEO · Avivia
Prism market signals · Netherlands · country-scoped Prism corpus, 130,015 docs

Market landscape — 10 sub-themes by coverage

Share of Healthcare coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Healthcare companies are there in Gelderland, Netherlands?
Radar tracks 48 indexable Healthcare companies headquartered in Gelderland, Netherlands that meet our profile-completeness bar.
What is the total funding raised by Healthcare companies in Gelderland, Netherlands?
The Healthcare companies in Gelderland, Netherlands on this list have raised a combined $30M in disclosed equity funding across 6 funded companies.
Which is the highest-funded Healthcare company in Gelderland, Netherlands?
Lead Pharma is the highest-funded Healthcare company in Gelderland, Netherlands, with $27.4M in disclosed equity funding.
How many Healthcare companies in Gelderland, Netherlands are funded?
6 of the 48 Healthcare companies in Gelderland, Netherlands on this list have disclosed at least one equity funding round.
How many Healthcare unicorns are there in Gelderland, Netherlands?
None of the Healthcare companies in Gelderland, Netherlands on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Gelderland, Netherlands Healthcare companies?
The most active investors in Gelderland, Netherlands Healthcare companies on this list include Europa, Oost NL, 819 Capital Partners, AIB CAPITAL & CO, BOM.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon